Zhen Bo Su
Direktor/Vorstandsmitglied bei CASI PHARMACEUTICALS, INC.
Profil
Mr. Zhen Bo Su is an Independent Director at CASI Pharmaceuticals, Inc., a Managing Partner at Shenzhen Share Investment LP and a Partner at Redhill Capital Investment Management Co. Ltd.
He is on the Board of Directors at CASI Pharmaceuticals, Inc. and Shenzhen Share Investment LP.
Mr. Su was previously employed as a Co-Founder by Chongqing TCR CURE Biopharma Technology Co., Ltd.
He received his undergraduate degree from Guangdong Medical University, a graduate degree from Sun Yat-Sen University and an MBA from The University of Chicago.
Aktive Positionen von Zhen Bo Su
Unternehmen | Position | Beginn |
---|---|---|
CASI PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 21.03.2023 |
Shenzhen Share Investment LP
Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Direktor/Vorstandsmitglied | - |
Redhill Capital Investment Management Co. Ltd. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Zhen Bo Su
Unternehmen | Position | Ende |
---|---|---|
Chongqing TCR CURE Biopharma Technology Co., Ltd
Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Gründer | - |
Ausbildung von Zhen Bo Su
Guangdong Medical University | Undergraduate Degree |
Sun Yat-Sen University | Graduate Degree |
The University of Chicago | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CASI PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Shenzhen Share Investment LP
Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Finance |
Chongqing TCR CURE Biopharma Technology Co., Ltd
Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Health Technology |
Redhill Capital Investment Management Co. Ltd. |